ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,572.85
0.10%
US Tech 100
19,893.60
0.00%
Dow Jones
39,344.79
-0.08%
Brent Oil
85.245
-0.20%
Bitcoin
57,281.47
1.01%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Vivoryon Therapeut (VVY) Quote

Vivoryon Therapeut

Vivoryon Therapeut (VVY)

EU
1.85
-0.054
( -2.84% )
Updated: 03:15:49
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
1.85
Bid
1.852
Ask
1.902
Volume
13,390
1.85 Day's Range 1.93
0.41 52 Week Range 14.10
Market Cap
-
Previous Close
1.904
Open
1.93
Last Trade
305
@
1.85
Last Trade Time
03:08:21
Financial Volume
-
VWAP
-
Average Volume (3m)
1,265,593
Shares Outstanding
0.00
Dividend Yield
-
PE Ratio
-
Earnings Per Share (EPS)
-
Revenue
-
Net Profit
-

About Vivoryon Therapeut

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.vivoryon.com
Headquarters
Halle, Deu
Founded
1970
Vivoryon Therapeut is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker VVY. The last closing price for Vivoryon Therapeut was 1.90 €. Over the last year, Vivoryon Therapeut shares have traded in a share price range of 0.41 € to 14.10 €.

Vivoryon Therapeut currently has 0 shares outstanding.

VVY Latest News

More News

Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease

Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on...

3 hours ago
UK Regulatory

Vivoryon Therapeutics N.V. Reports Outcome of 2024 Annual General Meeting

Vivoryon Therapeutics N.V. Reports Outcome of 2024 Annual General Meeting Vivoryon Therapeutics N.V. Reports Outcome of 2024 Annual General Meeting Halle (Saale) / Munich, Germany, June 21...

June 21 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. Reports Q1 2024 Financial Results and New Data Reinforcing Strategic Focus in Kidney Disease

Vivoryon Therapeutics N.V. Reports Q1 2024 Financial Results and New Data Reinforcing Strategic Focus in Kidney Disease Vivoryon Therapeutics N.V. Reports Q1 2024 Financial Results and New...

May 23 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. to Report Q1 2024 Financial Results and Operational Progress on May 23, 2024

Vivoryon Therapeutics N.V. to Report Q1 2024 Financial Results and Operational Progress on May 23, 2024 Vivoryon Therapeutics N.V. to Report Q1 2024 Financial Results and Operational Progress...

May 15 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. to Hold its 2024 Annual General Meeting on June 21, 2024

Vivoryon Therapeutics N.V. to Hold its 2024 Annual General Meeting on June 21, 2024 Vivoryon Therapeutics N.V. to Hold its 2024 Annual General Meeting on June 21, 2024 Halle (Saale) / Munich...

May 08 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates

Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and...

April 24 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. to Report Full Year 2023 Financial Results and Operational Progress on April 24, 2024

Vivoryon Therapeutics N.V. to Report Full Year 2023 Financial Results and Operational Progress on April 24, 2024 Vivoryon Therapeutics N.V. to Report Full Year 2023 Financial Results and...

April 16 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. Announces Changes to Board Composition

Vivoryon Therapeutics N.V. Announces Changes to Board Composition Vivoryon Therapeutics N.V. Announces Changes to Board Composition Halle (Saale) / Munich, Germany, March 15, 2024 – Vivoryon...

March 15 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.07-3.645833333331.921.981.851298641.93636037DE
4-0.665-26.44135188872.5152.6151.3245659771.95505163DE
121.3505270.370370370.49956.30.4112655932.1401134DE
26-6.28-77.24477244778.139.930.418781271.90427312DE
52-9.99-84.37511.8414.10.414686042.40746218DE
156-19.2-91.211401425221.0522.580.411990524.54257423DE
260-3.75-66.96428571435.623.250.411549645.54716833DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.175
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 62.2401
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.37
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.425
(0.00%)
0
AACGATA Creativity Global
$ 0.825
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.175
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 62.2401
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.37
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.425
(0.00%)
0
AACGATA Creativity Global
$ 0.825
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.175
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 62.2401
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.37
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.425
(0.00%)
0
AACGATA Creativity Global
$ 0.825
(0.00%)
0

Discussion

View Full Feed
ducci1 ducci1 4 minutes ago
SPX PIVOTS: Pivot--5572----R1--5583----R2--5593----R3--5604-----S1--5562----S2--5551----S3--5541 !
SPY
LUCKYBUTT LUCKYBUTT 6 minutes ago
What ever happened to that COVID P&D stock???? .0000000000000001 but yet they troll here
MONI
moola26 moola26 8 minutes ago
100% correct.
We are the majority and we are holding strong And there is nothing they can do about it other than post on this board 24/7 for the last 5 years. This is their strategy…. BwahahAHAHAWahah
MAJORITY HOLDING STRONGER
ramalio ramalio 14 minutes ago
I´ve these obvious ridiculous noisemakers/weisenheimers/FUD-spreaders all together (actually just 2 with their meanwhile wellknown agenda) on ignore.Typical, classical IHUB bashers like textbook! Hilarious!
Edit: Forgot that one of the 2 at least is so honest admitting being a shareholder - k
BMXI
Nukemtiltheyglow Nukemtiltheyglow 17 minutes ago
You mean Kiwi was wrong about Epadel waiting in the wings? Say it isn’t so….
It took Amarin and Eddingpharm years it seems to get China to approve Vazkepa.

Now all of a sudden “Mr Facto” blundered? The master of the innuendo.

Do the Chinese like the Japs? I mea
AMRN
littlejohn littlejohn 22 minutes ago
A much bigger threat from Beryl was

dodged...

Beryl injested dry air for almost

two days before landfall...

Beryl intensity increase from tropical

storm to hurricane only had about

six to eight hours to get the
knrorrel knrorrel 22 minutes ago
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174722632
RSPI
Seminole Red Seminole Red 22 minutes ago
with a 4 billion injection from VW, Rivian may be one of the few electric vehicles to be successful but its going to take a few years.....
RIVN
Jackxkr Jackxkr 22 minutes ago
You are the most worrhless little man here. Just am annoying little flea of a man. You like to here your own voice going cheep, cheep, cheep look at me. Tiny man syndrome written all over your post's.
NWBO
RichieBoy RichieBoy 22 minutes ago
IHUB privacy can be more like Public Commons.

Well at times anyway, sounds like you're probably signed out. I think if you sign back into IHUB things might look differently and more desireable.
AFFU
reindlll reindlll 24 minutes ago
More oure wish then knowledge
IGEN
EHRjunkie EHRjunkie 24 minutes ago
In yesterdays' tweet: IRB established.

The Institutional Review Board reviews and monitors biomedical research involving human subjects (Halberd is conducting clinical trials on Veterans and active duty personel). In accordance with FDA regulations, an IRB has the authority to approve
HALB
satter satter 24 minutes ago
The 2 Morons here with multiple user names keep posting about Project 2025, which is from The Heritage Foundation, which has NOTHING to do with MAGA


Heritage Foundation has NOTHING to do with MAGA/TRUMP?

Can those Maga lips lie any better than that?
DJT
knrorrel knrorrel 26 minutes ago
$30 wow crazy - back to $5 would be nice now

imho
MAXN
knrorrel knrorrel 27 minutes ago
why only Friday, could MAXN reach $1 as early as Thursday - is Friday an important day? ....... I think sooner or later MAXN could go back well above the dollar in 2024
imho

MAXN
Menace212 Menace212 29 minutes ago
All shareholders should take a look at this message I just sent
RSPI
RichieBoy RichieBoy 30 minutes ago
Mind linking that video please DJ?
Quite fascinating 🤨
AFFU
Menace212 Menace212 30 minutes ago
“Arnold S. Lippa, the Company’s Interim President and Interim Chief Executive Officer and the Company’s Chief Scientific Officer, and a director who was awarded 70,000,000 shares of Phantom Stock and Jeff Eliot Margolis, the Company’s Senior Vice President, Chief Financial Officer, Treasurer and Sec
RSPI
littlejohn littlejohn 33 minutes ago
Taiwan only has China and earthquakes to

watch out for everyday...

https://apnews.com/article/china-taiwan-safety-warning-af2bb9e74087acfef1f6c8677326d6d6

https://www.cwa.gov.tw/V8/E/E/index.html

The increase and ongoing seismic activity
declaes declaes 33 minutes ago
From the company:

More rev and income from the new beds at the beginning of July 2024!!!

ARIA will license the Building to operate 12 detox beds and 13 residential beds.   The new beds will be higher level care beds which will result in a roughly 50% increase in revenue
GRST
knrorrel knrorrel 35 minutes ago
WOW HEY , ALL READ THIS GREAT POST, 100% AGREEMENT


Good questions, none of which the 8k answers, so I’m not liking the response you got to be honest. The 8k was vague and if he chose to mention the EM and filings issue in the 8k, then he should have elaborated further. Becaus
RSPI
Wise Man Wise Man 36 minutes ago
MORE POTTING AND LESS PLOTTING.
https://x.com/CarlosVignote/status/1810239009139859803?t=sKvxCjI8L04rwQldSgBivg&s=19
FNMA
knrorrel knrorrel 37 minutes ago
WOW HEY , ALL READ THIS GREAT POST, 100% AGREEMENT


Good questions, none of which the 8k answers, so I’m not liking the response you got to be honest. The 8k was vague and if he chose to mention the EM and filings issue in the 8k, then he should have elaborated further. Becaus
RSPI

Your Recent History

EU
VVY
Vivoryon Therapeut
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved